Verve Therapeutics had a revenue of 32.98M in the quarter ending Mar 31, 2025, with 152.11%. This bring the company's revenue in the last twelve months to 59.61M, Decreased 84.38%. In the fiscal year ending Dec 31, 2024, Verve Therapeutics had annual revenue of 32.33M with 174.98% growth.